Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Psychological mechanisms in suicidal behaviour
ISRCTN ISRCTN55225822
ClinicalTrials.gov identifier
Public title Psychological mechanisms in suicidal behaviour
Scientific title
Acronym N/A
Serial number at source PRG/06/01
Study hypothesis This is a preliminary (explanatory) trial to assess the immediate effects of Mindfulness-based Cognitive Therapy (MBCT) on cognitive reactivity (the tendency to react to small changes in mood with a catastrophic and rapidly escalating pattern of suicidal thinking).
Lay summary
Ethics approval Not provided at time of registration.
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Suicidality
Participants - inclusion criteria 1. Aged 18 to 64
2. History of major depression with suicidal ideation and/or suicidal behaviour
3. Not currently depressed or suicidal (at least eight weeks symptom free)
Participants - exclusion criteria 1. Visually impaired
2. Not fluent in English
3. Habitual self-damaging acts
4. Bipolar disorder
5. Schizophrenia
6. Active substance abuse
7. Eating disorder
8. Primary Obsessive Compulsive Disorder (OCD)
Anticipated start date 01/05/2005
Anticipated end date 01/12/2005
Status of trial Completed
Patient information material
Target number of participants 12
Interventions Treatment:
Mindfulness-Based Cognitive Therapy (MBCT): manualised, eight week treatment combining stress reduction techniques and cognitive therapy and Treatment As Usual (TAU)

Control:
Waiting List control and Treatment As Usual (TAU)
Primary outcome measure(s) 1. Depression
2. Frequency of thought suppression
3. Change in problem solving and future thinking following experimental induction of mood
4. Self-rated mindfulness
5. Discrepancy between actual and ideal self-guides
6. Specificity of autobiographical memory
Secondary outcome measure(s) No secondary outcome measures
Sources of funding The Wellcome Trust (UK) (grant ref: 067797)
Trial website
Publications 2009 results in http://www.ncbi.nlm.nih.gov/pubmed/19254446
Contact name Prof  J. Mark G.  Williams
  Address Oxford University
Department of Psychiatry
Warneford Hospital
  City/town Oxford
  Zip/Postcode OX3 7JX
  Country United Kingdom
  Tel +44 (0)1865 226445
  Fax +44 (0)1865 223948
  Email mark.williams@psych.ox.ac.uk
Sponsor University of Oxford (UK)
  Address University Offices
Wellington Square
  City/town Oxford
  Zip/Postcode OX1 2JD
  Country United Kingdom
  Tel +44 (0)1865 270143
  Fax +44 (0)1865 280467
  Email researchservices@admin.ox.ac.uk
  Sponsor website: http://www.ox.ac.uk/
Date applied 03/03/2005
Last edited 10/05/2011
Date ISRCTN assigned 22/07/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central